|
SLC25A3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.635600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.836800E-01 |
| Normal-vs-Stage2 |
1.644270E-02 |
| Normal-vs-Stage3 |
4.422000E-01 |
| Normal-vs-Stage4 |
1.857960E-02 |
| Stage1-vs-Stage2 |
7.223900E-03 |
| Stage1-vs-Stage3 |
6.071200E-01 |
| Stage1-vs-Stage4 |
4.237600E-02 |
| Stage2-vs-Stage3 |
2.622600E-03 |
| Stage2-vs-Stage4 |
2.229200E-04 |
| Stage3-vs-Stage4 |
1.543000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.462000E-01 |
| Normal-vs-AfricanAmerican |
9.223400E-01 |
| Normal-vs-Asian |
6.336800E-01 |
| Caucasian-vs-AfricanAmerican |
5.927800E-01 |
| Caucasian-vs-Asian |
8.055800E-01 |
| AfricanAmerican-vs-Asian |
6.756200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.809200E-01 |
| Normal-vs-Female |
8.393400E-01 |
| Male-vs-Female |
7.642600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.639800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.868600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.478200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.924800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.832800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.455000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.344600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.797200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.828800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.580400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.040400E-02 |
| Classical-VS-Follicular |
1.133230E-01 |
| Classical-VS-Other |
3.951400E-01 |
| Classical-VS-Normal |
6.539800E-01 |
| Tall-VS-Follicular |
4.620100E-03 |
| Tall-VS-Other |
9.921200E-01 |
| Tall-VS-Normal |
2.059900E-02 |
| Follicular-VS-Other |
2.751400E-01 |
| Follicular-VS-Normal |
2.375200E-01 |
| Other-VS-Normal |
4.446000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.474400E-01 |
| Normal-vs-N1 |
8.983000E-04 |
| N0-vs-N1 |
1.275200E-03 |
|
|
